Related Experiment Video
Updated: Jun 4, 2025

08:27
Highly Sensitive and Rapid Fluorescence Detection with a Portable FRET Analyzer
Published on: October 1, 2016
9.0K
Highly Sensitive Flow Cytometry Biosensor with a High Signal-to-Background Ratio for FEN1 Analysis via Solid-Phase
Yong-Li Song1, Xiang-Lan He1, Yarong Guo2,3
1Tongji School of Pharmacy, Huazhong University of Science and Technology, Wuhan 430030, China.
Analytical Chemistry
|January 2, 2025
Summary
A new flow cytometry biosensor (FCsperA) offers highly sensitive detection of Flap endonuclease 1 (FEN1), an enzyme crucial in DNA repair and cancer progression. This method significantly improves detection limits and shows potential for cancer diagnostics and drug screening.
Area of Science:
- Biochemistry
- Molecular Biology
- Analytical Chemistry
Background:
- Flap endonuclease 1 (FEN1) is vital for DNA replication and repair.
- FEN1 overexpression correlates with tumor progression and drug resistance.
- Sensitive analytical methods for FEN1 detection are lacking.
Purpose of the Study:
- To develop a highly sensitive flow cytometry biosensor for FEN1 analysis.
- To improve upon existing primer exchange reaction amplification methods.
- To enable sensitive detection of FEN1 in biological samples and for inhibitor screening.
Main Methods:
- Development of a flow cytometry biosensor incorporating solid-phase interface-mediated primer exchange reaction amplification (s-PER).
- Comparison of s-PER with homogeneous PER amplification (h-PER).
- Assay validation using FEN1 standards, cell samples, and serum samples.
Main Results:
- Solid-phase PER amplification (s-PER) significantly suppressed background noise, achieving a signal-to-background ratio over 46-fold higher than h-PER.
- The developed FCsperA biosensor demonstrated high sensitivity with a limit of detection (LOD) of 2.53 × 10-6 U/μL for FEN1.
- FCsperA showed excellent selectivity, anti-interference ability, and was capable of detecting FEN1 in approximately 10 cancer cells and serum samples.
Conclusions:
- FCsperA provides a highly sensitive and selective method for FEN1 detection.
- The biosensor is applicable for analyzing FEN1 in complex biological matrices like cells and serum.
- FCsperA holds promise for clinical diagnostics and the screening of FEN1 inhibitors for cancer therapy.

